Kyle M. Schachtschneider, PhD (he/him/his)

Vice President of R&D, Services
Sus Clinicals Inc., United States

Presentation(s):

• 65 - Porcine-based Platform for Image-guided Delivery of Allogeneic Natural Killer Cell Immunotherapy

  Monday, April 13, 2026
  12:10 PM - 1:10 PM ET

• Liquid Biopsy Detection of TP53, mGSTP1, and mRASS1Fa from Circulating Tumor DNA Improves the Non-invasive Diagnosis of Hepatocellular Carcinoma

  Monday, April 13, 2026
  3:09 PM - 3:18 PM ET